Hot off the press: |transkript 4/2024
|transkript, one of our German magazines, has been the leading industry publication for biotechnology and life sciences in German-speaking Europe since 1995. It covers current information, opinions, and background on business, research, and politics. In this issue:
Mainz-based BioNTech SE was an early adopter in developing algorithms to produce personalised mRNA therapeutics for cancer treatment—a feat other mRNA companies have also achieved. However, at the company’s first AI Day, its UK subsidiary InstaDeep took the spotlight, positioning the joint venture at the very heart of the AI whirlwind.
Also in this issue:
- BioNTech: All in on AI
- Brain Biotech AG sells pharmaceutical rights to Royalty Pharma
- Interview: Werner Lanthaler, first conversation with the former CEO of Evotec SE
- Immatics advances IMA-203 to Phase III and raises capital
- Interview: Prof. Dr. Andreas Eckert, Chairman of the Supervisory Board, Pentixapharm Holding AG
- Nobel Prizes for miRNAs and AI in protein structure prediction
- Food biotech – Fungal cheese in supermarkets
- Interview: Martin Krauss, Chairman, Federal Association of Contract Research Organisations (BVMA)
- Start-ups
- |transkript personal: Dr. Sebastian Raakers, BLUU Seafood GmbH
- Tech-Park-Spezial
- Laborwelt-Spezial: Diagnostik
- Schwerpunkt Medtech-zwo
Read the issue here (in German).